Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208


Regulation of Cell-Cell Adhesion in Prostate Cancer Cells by microRNA-96 through Upregulation of E-Cadherin and EpCAM.

Voss G, Haflidadóttir BS, Järemo H, Persson M, Catela Ivkovic T, Wikström P, Ceder Y.

Carcinogenesis. 2019 Nov 18. pii: bgz191. doi: 10.1093/carcin/bgz191. [Epub ahead of print]


Modulation of COX-2, INF-ɣ, glutamatergic and opioid systems contributes to antinociceptive, anti-inflammatory and anti-hyperalgesic effects of bis(3-amino-2-pyridine) diselenide.

Reis AS, Vogt AG, Pinz MP, Voss GT, da Fonseca CAR, Paltian JJ, Peglow TJ, Vaucher RA, Echenique JVZ, Soares MP, Schumacher RF, Perin G, Luchese C, Wilhelm EA.

Chem Biol Interact. 2019 Sep 25;311:108790. doi: 10.1016/j.cbi.2019.108790. Epub 2019 Aug 7.


New hope for tuberculosis vaccines.

Olesen OF, Abdullah F, Coppens R, Gardner PJ, Ginsberg AM, Hanekom WA, Laang H, Lewinsohn DM, Loots G, Schmidt A, Vekemans J, Voss GH.

Lancet Infect Dis. 2019 Jul;19(7):687-688. doi: 10.1016/S1473-3099(19)30280-4. No abstract available.


Contribution of serotonergic and nitrergic pathways, as well as monoamine oxidase-a and Na+, K+-ATPase enzymes in antidepressant-like action of ((4-tert-butylcyclohexylidene) methyl) (4-methoxystyryl) sulfide (BMMS).

de Oliveira RL, Voss GT, Paltian JJ, Pinz MP, Torres MLCP, Moreira MP, Dilelio MC, Silveira CC, Wilhelm EA, Luchese C.

Metab Brain Dis. 2019 Oct;34(5):1313-1324. doi: 10.1007/s11011-019-00436-x. Epub 2019 Jun 8.


Synthesis of chitosan derivatives with organoselenium and organosulfur compounds: Characterization, antimicrobial properties and application as biomaterials.

Gularte MS, Anghinoni JM, Abenante L, Voss GT, de Oliveira RL, Vaucher RA, Luchese C, Wilhelm EA, Lenardão EJ, Fajardo AR.

Carbohydr Polym. 2019 Sep 1;219:240-250. doi: 10.1016/j.carbpol.2019.05.040. Epub 2019 May 11.


Polysaccharide-based film loaded with vitamin C and propolis: A promising device to accelerate diabetic wound healing.

Voss GT, Gularte MS, Vogt AG, Giongo JL, Vaucher RA, Echenique JVZ, Soares MP, Luchese C, Wilhelm EA, Fajardo AR.

Int J Pharm. 2018 Dec 1;552(1-2):340-351. doi: 10.1016/j.ijpharm.2018.10.009. Epub 2018 Oct 6.


Forgotten fatty acids-Surface properties supply conclusive evidence for including carotenoic acids.

Zaidi A, Alsvik IL, Øpstad CL, Martin D, Rebman E, Voss G, Sliwka HR, Partali V.

Chem Phys Lipids. 2018 Nov;216:48-53. doi: 10.1016/j.chemphyslip.2018.09.001. Epub 2018 Sep 25.


Progress and challenges in TB vaccine development.

Voss G, Casimiro D, Neyrolles O, Williams A, Kaufmann SHE, McShane H, Hatherill M, Fletcher HA.

F1000Res. 2018 Feb 16;7:199. doi: 10.12688/f1000research.13588.1. eCollection 2018. Review.


Therapeutic and technological potential of 7-chloro-4-phenylselanyl quinoline for the treatment of atopic dermatitis-like skin lesions in mice.

Voss GT, Oliveira RL, de Souza JF, Duarte LFB, Fajardo AR, Alves D, Luchese C, Wilhelm EA.

Mater Sci Eng C Mater Biol Appl. 2018 Mar 1;84:90-98. doi: 10.1016/j.msec.2017.11.026. Epub 2017 Nov 23.


Organoselenium group is critical for antioxidant activity of 7-chloro-4-phenylselenyl-quinoline.

Vogt AG, Voss GT, de Oliveira RL, Paltian JJ, Duarte LFB, Alves D, Jesse CR, Roman SS, Roehrs JA, Wilhelm EA, Luchese C.

Chem Biol Interact. 2018 Feb 25;282:7-12. doi: 10.1016/j.cbi.2018.01.003. Epub 2018 Jan 6.


Organoselenium compounds from purines: Synthesis of 6-arylselanylpurines with antioxidant and anticholinesterase activities and memory improvement effect.

Duarte LFB, Oliveira RL, Rodrigues KC, Voss GT, Godoi B, Schumacher RF, Perin G, Wilhelm EA, Luchese C, Alves D.

Bioorg Med Chem. 2017 Dec 15;25(24):6718-6723. doi: 10.1016/j.bmc.2017.11.019. Epub 2017 Nov 10.


7-Chloro-4-phenylsulfonyl quinoline, a new antinociceptive and anti-inflammatory molecule: Structural improvement of a quinoline derivate with pharmacological activity.

Pinz MP, Reis AS, de Oliveira RL, Voss GT, Vogt AG, Sacramento MD, Roehrs JA, Alves D, Luchese C, Wilhelm EA.

Regul Toxicol Pharmacol. 2017 Nov;90:72-77. doi: 10.1016/j.yrtph.2017.08.014. Epub 2017 Aug 23.


Selective A2A receptor antagonist SCH 58261 modulates striatal oxidative stress and alleviates toxicity induced by 3-Nitropropionic acid in male Wistar rats.

Bortolatto CF, Reis AS, Pinz MP, Voss GT, Oliveira RL, Vogt AG, Roman S, Jesse CR, Luchese C, Wilhelm EA.

Metab Brain Dis. 2017 Dec;32(6):1919-1927. doi: 10.1007/s11011-017-0086-1. Epub 2017 Aug 9.


microRNAs as cancer therapeutics: A step closer to clinical application.

Catela Ivkovic T, Voss G, Cornella H, Ceder Y.

Cancer Lett. 2017 Oct 28;407:113-122. doi: 10.1016/j.canlet.2017.04.007. Epub 2017 Apr 12. Review.


Development, characterization and biocompatibility of chondroitin sulfate/poly(vinyl alcohol)/bovine bone powder porous biocomposite.

da Silva GT, Voss GT, Kaplum V, Nakamura CV, Wilhelm EA, Luchese C, Fajardo AR.

Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:526-535. doi: 10.1016/j.msec.2016.11.069. Epub 2016 Nov 22.


Influence of apixaban on antifactor Xa levels in a patient with acute kidney injury.

Wendte J, Voss G, VanOverschelde B.

Am J Health Syst Pharm. 2016 Apr 15;73(8):563-7. doi: 10.2146/ajhp150360.


The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.

Diederichs S, Bartsch L, Berkmann JC, Fröse K, Heitmann J, Hoppe C, Iggena D, Jazmati D, Karschnia P, Linsenmeier M, Maulhardt T, Möhrmann L, Morstein J, Paffenholz SV, Röpenack P, Rückert T, Sandig L, Schell M, Steinmann A, Voss G, Wasmuth J, Weinberger ME, Wullenkord R.

EMBO Mol Med. 2016 May 2;8(5):442-57. doi: 10.15252/emmm.201506055. Print 2016 May. Review.


Bioactive properties of peptides obtained from Argentinian defatted soy flour protein by Corolase PP hydrolysis.

Coscueta ER, Amorim MM, Voss GB, Nerli BB, Picó GA, Pintado ME.

Food Chem. 2016 May 1;198:36-44. doi: 10.1016/j.foodchem.2015.11.068. Epub 2015 Nov 17.


Response to the comment on "Halogenated indigo dyes: A likely source of 1,3,6,8-tetrabromocarbazole and some other halogenated carbazoles in the environment".

Parette R, McCrindle R, McMahon KS, Pena-Abaurrea M, Reiner E, Chittim B, Riddell N, Voss G, Dorman FL, Pearson WN, Robson M.

Chemosphere. 2016 May;150:414-415. doi: 10.1016/j.chemosphere.2015.11.033. Epub 2015 Dec 8. No abstract available.


Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.

Ockenhouse CF, Regules J, Tosh D, Cowden J, Kathcart A, Cummings J, Paolino K, Moon J, Komisar J, Kamau E, Oliver T, Chhoeu A, Murphy J, Lyke K, Laurens M, Birkett A, Lee C, Weltzin R, Wille-Reece U, Sedegah M, Hendriks J, Versteege I, Pau MG, Sadoff J, Vanloubbeeck Y, Lievens M, Heerwegh D, Moris P, Guerra Mendoza Y, Jongert E, Cohen J, Voss G, Ballou WR, Vekemans J.

PLoS One. 2015 Jul 6;10(7):e0131571. doi: 10.1371/journal.pone.0131571. eCollection 2015.


Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.

Barouch DH, Alter G, Broge T, Linde C, Ackerman ME, Brown EP, Borducchi EN, Smith KM, Nkolola JP, Liu J, Shields J, Parenteau L, Whitney JB, Abbink P, Ng'ang'a DM, Seaman MS, Lavine CL, Perry JR, Li W, Colantonio AD, Lewis MG, Chen B, Wenschuh H, Reimer U, Piatak M, Lifson JD, Handley SA, Virgin HW, Koutsoukos M, Lorin C, Voss G, Weijtens M, Pau MG, Schuitemaker H.

Science. 2015 Jul 17;349(6245):320-4. doi: 10.1126/science.aab3886. Epub 2015 Jul 2.


A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.

Omosa-Manyonyi G, Mpendo J, Ruzagira E, Kilembe W, Chomba E, Roman F, Bourguignon P, Koutsoukos M, Collard A, Voss G, Laufer D, Stevens G, Hayes P, Clark L, Cormier E, Dally L, Barin B, Ackland J, Syvertsen K, Zachariah D, Anas K, Sayeed E, Lombardo A, Gilmour J, Cox J, Fast P, Priddy F.

PLoS One. 2015 May 11;10(5):e0125954. doi: 10.1371/journal.pone.0125954. eCollection 2015.


Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.

Lorin C, Vanloubbeeck Y, Baudart S, Ska M, Bayat B, Brauers G, Clarinval G, Donner MN, Marchand M, Koutsoukos M, Mettens P, Cohen J, Voss G.

PLoS One. 2015 Apr 9;10(4):e0122835. doi: 10.1371/journal.pone.0122835. eCollection 2015.


Halogenated indigo dyes: a likely source of 1,3,6,8-tetrabromocarbazole and some other halogenated carbazoles in the environment.

Parette R, McCrindle R, McMahon KS, Pena-Abaurrea M, Reiner E, Chittim B, Riddell N, Voss G, Dorman FL, Pearson WN.

Chemosphere. 2015 May;127:18-26. doi: 10.1016/j.chemosphere.2015.01.001. Epub 2015 Jan 29. Review.


Hydrogen-bonded organic semiconductor micro- and nanocrystals: from colloidal syntheses to (opto-)electronic devices.

Sytnyk M, Głowacki ED, Yakunin S, Voss G, Schöfberger W, Kriegner D, Stangl J, Trotta R, Gollner C, Tollabimazraehno S, Romanazzi G, Bozkurt Z, Havlicek M, Sariciftci NS, Heiss W.

J Am Chem Soc. 2014 Nov 26;136(47):16522-32. doi: 10.1021/ja5073965. Epub 2014 Oct 10.


Embracing the "and": between queer and bisexual theory at Brighton BiFest.

Voss G, Browne K, Gupta C.

J Homosex. 2014;61(11):1605-25. doi: 10.1080/00918369.2014.944055.


Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults.

Kester KE, Gray Heppner D Jr, Moris P, Ofori-Anyinam O, Krzych U, Tornieporth N, McKinney D, Delchambre M, Ockenhouse CF, Voss G, Holland C, Beckey JP, Ballou WR, Cohen J; RTS,S/TRAP Group.

Vaccine. 2014 Nov 20;32(49):6683-91. doi: 10.1016/j.vaccine.2014.06.033. Epub 2014 Jun 18.


Immunogenicity of a recombinant measles HIV-1 subtype C vaccine.

Stebbings R, Li B, Lorin C, Koutsoukos M, Février M, Mee ET, Page M, Almond N, Tangy F, Voss G.

Vaccine. 2013 Dec 9;31(51):6079-86. doi: 10.1016/j.vaccine.2013.09.072. Epub 2013 Oct 24.


25th anniversary article: progress in chemistry and applications of functional indigos for organic electronics.

Głowacki ED, Voss G, Sariciftci NS.

Adv Mater. 2013 Dec 17;25(47):6783-800. doi: 10.1002/adma.201302652. Epub 2013 Oct 22.


Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.

Harrer T, Plettenberg A, Arastéh K, Van Lunzen J, Fätkenheuer G, Jaeger H, Janssens M, Burny W, Collard A, Roman F, Loeliger A, Koutsoukos M, Bourguignon P, Lavreys L, Voss G.

Vaccine. 2014 May 7;32(22):2657-65. doi: 10.1016/j.vaccine.2013.10.030. Epub 2013 Oct 19.


Variation in salamander tail regeneration is associated with genetic factors that determine tail morphology.

Voss GJ, Kump DK, Walker JA, Voss SR.

PLoS One. 2013 Jul 3;8(7):e67274. doi: 10.1371/journal.pone.0067274. Print 2013.


A facile protection-deprotection route for obtaining indigo pigments as thin films and their applications in organic bulk heterojunctions.

Głowacki ED, Voss G, Demirak K, Havlicek M, Sünger N, Okur AC, Monkowius U, Gąsiorowski J, Leonat L, Sariciftci NS.

Chem Commun (Camb). 2013 Jul 11;49(54):6063-5. doi: 10.1039/c3cc42889c.


Vacuum-processed polyethylene as a dielectric for low operating voltage organic field effect transistors.

Kanbur Y, Irimia-Vladu M, Głowacki ED, Voss G, Baumgartner M, Schwabegger G, Leonat L, Ullah M, Sarica H, Erten-Ela S, Schwödiauer R, Sitter H, Küçükyavuz Z, Bauer S, Sariciftci NS.

Org Electron. 2012 May;13(5):919-924.


Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine.

Stebbings R, Février M, Li B, Lorin C, Koutsoukos M, Mee E, Rose N, Hall J, Page M, Almond N, Voss G, Tangy F.

PLoS One. 2012;7(11):e50397. doi: 10.1371/journal.pone.0050397. Epub 2012 Nov 30.


Electrocardiographic findings in chronic hemodialysis patients.

Bignotto LH, Kallás ME, Djouki RJ, Sassaki MM, Voss GO, Soto CL, Frattini F, Medeiros FS.

J Bras Nefrol. 2012 Jul-Sep;34(3):235-42.


Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques.

Lorin C, Segal L, Mols J, Morelle D, Bourguignon P, Rovira O, Mettens P, Silvano J, Dumey N, Le Goff F, Koutsoukos M, Voss G, Tangy F.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Dec;385(12):1211-25. doi: 10.1007/s00210-012-0793-4. Epub 2012 Sep 16.


Thyroid hormone responsive QTL and the evolution of paedomorphic salamanders.

Voss SR, Kump DK, Walker JA, Shaffer HB, Voss GJ.

Heredity (Edinb). 2012 Nov;109(5):293-8. doi: 10.1038/hdy.2012.41. Epub 2012 Aug 1.


Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.

Page M, Stebbings R, Berry N, Hull R, Ferguson D, Davis L, Duffy L, Elsley W, Hall J, Ham C, Hassall M, Li B, Mee ET, Quartey-Papafio R, Rose NJ, Mathy N, Voss G, Stott EJ, Almond N.

Retrovirology. 2012 Jul 16;9:56. doi: 10.1186/1742-4690-9-56.


Gaming, texting, learning? Teaching engineering ethics through students' lived experiences with technology.

Voss G.

Sci Eng Ethics. 2013 Sep;19(3):1375-93. doi: 10.1007/s11948-012-9368-5. Epub 2012 May 16.


HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages.

Moody MA, Yates NL, Amos JD, Drinker MS, Eudailey JA, Gurley TC, Marshall DJ, Whitesides JF, Chen X, Foulger A, Yu JS, Zhang R, Meyerhoff RR, Parks R, Scull JC, Wang L, Vandergrift NA, Pickeral J, Pollara J, Kelsoe G, Alam SM, Ferrari G, Montefiori DC, Voss G, Liao HX, Tomaras GD, Haynes BF.

J Virol. 2012 Jul;86(14):7496-507. doi: 10.1128/JVI.00426-12. Epub 2012 May 2.


Excited state characterization of a polymeric indigo.

Rondão R, Seixas de Melo J, Schaberle FA, Voss G.

Phys Chem Chem Phys. 2012 Feb 7;14(5):1778-83. doi: 10.1039/c2cp23266a. Epub 2011 Dec 14.


Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated.

Liao HX, Chen X, Munshaw S, Zhang R, Marshall DJ, Vandergrift N, Whitesides JF, Lu X, Yu JS, Hwang KK, Gao F, Markowitz M, Heath SL, Bar KJ, Goepfert PA, Montefiori DC, Shaw GC, Alam SM, Margolis DM, Denny TN, Boyd SD, Marshal E, Egholm M, Simen BB, Hanczaruk B, Fire AZ, Voss G, Kelsoe G, Tomaras GD, Moody MA, Kepler TB, Haynes BF.

J Exp Med. 2011 Oct 24;208(11):2237-49. doi: 10.1084/jem.20110363. Epub 2011 Oct 10.


Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.

Lichterfeld M, Gandhi RT, Simmons RP, Flynn T, Sbrolla A, Yu XG, Basgoz N, Mui S, Williams K, Streeck H, Burgett-Yandow N, Roy G, Janssens M, Pedneault L, Vandepapelière P, Koutsoukos M, Demoitié MA, Bourguignon P, McNally L, Voss G, Altfeld M.

J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):1-9. doi: 10.1097/QAI.0b013e3182373b77.


An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteers.

Van Braeckel E, Bourguignon P, Koutsoukos M, Clement F, Janssens M, Carletti I, Collard A, Demoitié MA, Voss G, Leroux-Roels G, McNally L.

Clin Infect Dis. 2011 Feb 15;52(4):522-31. doi: 10.1093/cid/ciq160. Epub 2011 Jan 5.


Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation.

Cranage MP, Fraser CA, Cope A, McKay PF, Seaman MS, Cole T, Mahmoud AN, Hall J, Giles E, Voss G, Page M, Almond N, Shattock RJ.

Vaccine. 2011 Feb 4;29(7):1421-30. doi: 10.1016/j.vaccine.2010.12.034. Epub 2010 Dec 25.


Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

Leroux-Roels I, Koutsoukos M, Clement F, Steyaert S, Janssens M, Bourguignon P, Cohen K, Altfeld M, Vandepapelière P, Pedneault L, McNally L, Leroux-Roels G, Voss G.

Vaccine. 2010 Oct 8;28(43):7016-24. doi: 10.1016/j.vaccine.2010.08.035. Epub 2010 Aug 20.


Characterization of the excited states of indigo derivatives in their reduced forms.

Rondão R, Seixas de Melo JS, Voss G.

Chemphyschem. 2010 Jun 21;11(9):1903-8. doi: 10.1002/cphc.201000082.


Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.

Pichyangkul S, Tongtawe P, Kum-Arb U, Yongvanitchit K, Gettayacamin M, Hollingdale MR, Limsalakpetch A, Stewart VA, Lanar DE, Dutta S, Angov E, Ware LA, Bergmann-Leitner ES, House B, Voss G, Dubois MC, Cohen JD, Fukuda MM, Heppner DG, Miller RS.

Vaccine. 2009 Dec 11;28(2):452-62. doi: 10.1016/j.vaccine.2009.10.022. Epub 2009 Oct 24.


Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site.

Dey B, Svehla K, Xu L, Wycuff D, Zhou T, Voss G, Phogat A, Chakrabarti BK, Li Y, Shaw G, Kwong PD, Nabel GJ, Mascola JR, Wyatt RT.

PLoS Pathog. 2009 May;5(5):e1000445. doi: 10.1371/journal.ppat.1000445. Epub 2009 May 29.


Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaques.

Koopman G, Mortier D, Hofman S, Koutsoukos M, Bogers WMJM, Wahren B, Voss G, Heeney JL.

J Gen Virol. 2009 Apr;90(Pt 4):915-926. doi: 10.1099/vir.2008.006148-0. Epub 2009 Feb 17.


Supplemental Content

Support Center